Giuseppe Lombardi, Head of the Neuro-Oncology Unit at Veneto Oncology Institute IOV – IRCCS, shared on LinkedIn:
“A prestigious international recognition!
We are extremely proud to celebrate Alberto Bosio, who received the ESMO Merit Award 2026 at the ESMO Congress in Madrid for presenting the results of our VORAFET study.
The ESMO Merit Award recognizes outstanding scientific contributions from young researchers, highlighting the quality and relevance of their work in advancing cancer research.
Congratulations, Alberto, on this well-deserved recognition!
A heartfelt thank you to all co-authors and collaborators whose dedication and teamwork made this achievement possible.
Read our study in Neuro-Oncology:
Title: Longitudinal PET RANO 1.0 and RANO 2.0 response assessment in vorasidenib-treated IDH-mutant gliomas: the VORAFET study
Authors: Giuseppe Lombardi, Alberto Bosio, Giovanni Librizzi, Mariagiulia Anglani, Tamara Ius, Mario Caccese, Marta Padovan, Francesco Cavallin, Marta Maccari, Francesco Volpin, Francesco Pasqualetti, Rossella Simeone, Alessandro Parisi, Alessandro Salvalaggio, Luisa Bellu, Luca Denaro, Sara Lonardi, Matthias Preusser, Nathalie L Albert, Diego Cecchin
Other articles about ESMO26 and Neuro-Oncology on OncoDaily.